感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2018 专家共识：降钙素原指导抗生素治疗

2018-06-06 国外感染病相关专家组（统称） Clin Chem Lab Med. 2018 Jun 6.

降钙素原抗生素治疗

降钙素原是一种与细菌感染相关的标志物，降钙素原指导抗生素治疗可缩短抗生素治疗时间。本文的主要目的是确定恰当使用降钙素原以提高脓毒症危重患者的管理水平。

中文标题：

2018 专家共识：降钙素原指导抗生素治疗

英文标题：

Procalcitonin-guided antibiotic therapy: an expert consensus.

发布机构：

国外感染病相关专家组（统称）

发布日期：

2018-06-06

简要介绍：

降钙素原是一种与细菌感染相关的标志物，降钙素原指导抗生素治疗可缩短抗生素治疗时间。本文的主要目的是确定恰当使用降钙素原以提高脓毒症危重患者的管理水平。 

拓展指南：与抗生素相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 专家共识：降钙素原指导抗生素治疗)] GetToolGuiderByIdResponse(projectId=1, id=7bb791c00160a624, title=2018 专家共识：降钙素原指导抗生素治疗, enTitle=Procalcitonin-guided antibiotic therapy: an expert consensus., guiderFrom=Clin Chem Lab Med. 2018 Jun 6., authorId=null, author=, summary=降钙素原是一种与细菌感染相关的标志物，降钙素原指导抗生素治疗可缩短抗生素治疗时间。本文的主要目的是确定恰当使用降钙素原以提高脓毒症危重患者的管理水平。 , cover=, journalId=null, articlesId=null, associationId=1273, associationName=国外感染病相关专家组（统称）, associationIntro=, copyright=0, guiderPublishedTime=Wed Jun 06 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>降钙素原是一种与细菌感染相关的标志物，降钙素原指导抗生素治疗可缩短抗生素治疗时间。本文的主要目的是确定恰当使用降钙素原以提高脓毒症危重患者的管理水平。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>抗生素</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=952111c0015586d2" title="2018 临床实践指南：简单皮肤脓肿切开引流后抗生素应用" target=_blank>2018 临床实践指南：简单皮肤脓肿切开引流后抗生素应用</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=2f0951c0015a5655" title="2018 日本指南：急性胆管炎和胆囊炎的抗生素治疗" target=_blank>2018 日本指南：急性胆管炎和胆囊炎的抗生素治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=254771c0015a18f8" title="2017 KSID临床指南：社区获得性皮肤和软组织感染的抗生素治疗" target=_blank>2017 KSID临床指南：社区获得性皮肤和软组织感染的抗生素治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=eb3b81c001a303c7" title="欧洲牙髓病学会（ESE）关于“牙髓病治疗中抗生素使用”的立场声明" target=_blank>欧洲牙髓病学会（ESE）关于“牙髓病治疗中抗生素使用”的立场声明</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=721f21c001a2197d" title="2017 ESE立场声明：牙髓病学中抗生素的应用" target=_blank>2017 ESE立场声明：牙髓病学中抗生素的应用</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E6%8A%97%E7%94%9F%E7%B4%A0" target=_blank>有关抗生素更多指南</a></ul>, tagList=[TagDto(tagId=17996, tagName=降钙素原), TagDto(tagId=4247, tagName=抗生素治疗)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9559, appHits=859, showAppHits=0, pcHits=5897, showPcHits=4062, likes=109, shares=36, comments=8, approvalStatus=1, publishedTime=Mon Jun 18 21:34:30 CST 2018, publishedTimeString=2018-06-06, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Jun 18 21:34:30 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:39:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 专家共识：降钙素原指导抗生素治疗)])
2018 专家共识：降钙素原指导抗生素治疗
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1010140, encodeId=c5a3101014086, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44a15499933, createdName=山落, createdTime=Sat Aug 21 21:17:32 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005018, encodeId=819910050185e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71855418232, createdName=ms9000001618803930, createdTime=Wed Aug 04 00:27:12 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957195, encodeId=877495e195a0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5912104845, createdName=tomwong, createdTime=Thu Apr 15 09:24:10 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325630, encodeId=f689325630d5, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Wed Jun 20 17:13:25 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325606, encodeId=a0fc3256066a, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 20 13:05:31 CST 2018, time=2018-06-20, status=1, ipAttribution=)]
    2021-08-21 山落

    学到了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1010140, encodeId=c5a3101014086, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44a15499933, createdName=山落, createdTime=Sat Aug 21 21:17:32 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005018, encodeId=819910050185e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71855418232, createdName=ms9000001618803930, createdTime=Wed Aug 04 00:27:12 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957195, encodeId=877495e195a0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5912104845, createdName=tomwong, createdTime=Thu Apr 15 09:24:10 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325630, encodeId=f689325630d5, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Wed Jun 20 17:13:25 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325606, encodeId=a0fc3256066a, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 20 13:05:31 CST 2018, time=2018-06-20, status=1, ipAttribution=)]
    2021-08-04 ms9000001618803930

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1010140, encodeId=c5a3101014086, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44a15499933, createdName=山落, createdTime=Sat Aug 21 21:17:32 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005018, encodeId=819910050185e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71855418232, createdName=ms9000001618803930, createdTime=Wed Aug 04 00:27:12 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957195, encodeId=877495e195a0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5912104845, createdName=tomwong, createdTime=Thu Apr 15 09:24:10 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325630, encodeId=f689325630d5, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Wed Jun 20 17:13:25 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325606, encodeId=a0fc3256066a, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 20 13:05:31 CST 2018, time=2018-06-20, status=1, ipAttribution=)]
    2021-04-15 tomwong

    好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1010140, encodeId=c5a3101014086, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44a15499933, createdName=山落, createdTime=Sat Aug 21 21:17:32 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005018, encodeId=819910050185e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71855418232, createdName=ms9000001618803930, createdTime=Wed Aug 04 00:27:12 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957195, encodeId=877495e195a0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5912104845, createdName=tomwong, createdTime=Thu Apr 15 09:24:10 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325630, encodeId=f689325630d5, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Wed Jun 20 17:13:25 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325606, encodeId=a0fc3256066a, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 20 13:05:31 CST 2018, time=2018-06-20, status=1, ipAttribution=)]
    2018-06-20 三生有幸9135

    学习一下

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1010140, encodeId=c5a3101014086, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44a15499933, createdName=山落, createdTime=Sat Aug 21 21:17:32 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005018, encodeId=819910050185e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71855418232, createdName=ms9000001618803930, createdTime=Wed Aug 04 00:27:12 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957195, encodeId=877495e195a0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5912104845, createdName=tomwong, createdTime=Thu Apr 15 09:24:10 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325630, encodeId=f689325630d5, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Wed Jun 20 17:13:25 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325606, encodeId=a0fc3256066a, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 20 13:05:31 CST 2018, time=2018-06-20, status=1, ipAttribution=)]
    2018-06-20 大爰

    学习了谢谢分享!!

    0

相关指南

2012 降钙素原 （PCT）急诊临床应用的专家共识

暂未更新 · 2012-09-10